Track Arvaya Healthcare Ltd.'s current share price, historical price chart, 52-week high/low, and performance across different time periods.
1 Week returns: 10.19 %
Low
110.2
High
119.0
1 Month returns: -14.64 %
Low
105.9
High
145.0
1 Year returns: 392.75 %
Low
25.4
High
145.0
3 Year CAGR: -
Low
20.5
High
145.0
5 Year CAGR: -
Low
20.5
High
145.0
Note: Prices may be delayed by a few minutes. For historical calculations, prices are adjusted for splits, bonus and rights issue. Percentage change shown is absolute irrespective of the period.
Multi-year trends for Arvaya Healthcare Ltd. covering revenue, net profit, ROE, and EBITDA for a quick view of financial health over time.
Arvaya Healthcare Ltd. Shareholding Pattern
Quarterly breakdown of Arvaya Healthcare Ltd. ownership including promoter, FII, DII, mutual fund, and public holdings as disclosed to NSE/BSE.
Bulk, Block and Insider Trades
Recent bulk deals, block deals, and insider trading activity in Arvaya Healthcare Ltd. shares as reported to NSE and BSE.
Frequently Asked Questions
What is the current share price of Arvaya Healthcare Ltd.?
The current share price of Arvaya Healthcare Ltd. is ₹ 119.00 as of 25 Aug 2026.
What is the market capitalisation of Arvaya Healthcare Ltd.?
The market capitalisation of Arvaya Healthcare Ltd. stands at ₹ 571.46 Cr.
What is the PE ratio of Arvaya Healthcare Ltd.?
The Price-to-Earnings (PE) ratio of Arvaya Healthcare Ltd. is - as of the latest trailing twelve months data.
What is the ROE and ROCE of Arvaya Healthcare Ltd.?
Arvaya Healthcare Ltd. has a Return on Equity (ROE) of 2.85% and a Return on Capital Employed (ROCE) of 0.19% as per the latest financial reports.
What is the 52-week high and low of Arvaya Healthcare Ltd.?
The 52-week high of Arvaya Healthcare Ltd. is - and the 52-week low is -.
What is the dividend yield of Arvaya Healthcare Ltd.?
The dividend yield of Arvaya Healthcare Ltd. is 0.00% based on the current market price.
What is the FII and DII holding in Arvaya Healthcare Ltd.?
Foreign Institutional Investors (FII) hold 0.00%, Domestic Institutional Investors (DII) hold 0.00% and retail/public investors hold 68.15% of Arvaya Healthcare Ltd. shares.
What sector does Arvaya Healthcare Ltd. belong to?
Arvaya Healthcare Ltd. operates in the Services sector.
What is the beta of Arvaya Healthcare Ltd.?
The beta of Arvaya Healthcare Ltd. is -0.12, indicating its price volatility relative to the broader market.
What is the RSI of Arvaya Healthcare Ltd.?
The 14-day Relative Strength Index (RSI) of Arvaya Healthcare Ltd. is 60.74, placing it approaching overbought territory. An RSI above 70 is considered overbought and below 30 is considered oversold.
Stock Analysis
Fundamental analysis overview of Arvaya Healthcare Ltd. covering key investment insights, growth drivers, risk factors, and potential red flags.
Views
Red Flags
Positive
Strong revenue growth and above median growth of industry
The company delivered strong revenue growth of 20165.9% for 12-month ended 30 Jun 2026 and the growth was 20164.74 percentage points higher than median growth of industry
What is Sales growth (1Y)?
Median: 1.16
Value 20165.9
-127.35379742
Negative
Stock is fairly expensive with negative EPS on a trailing 12-month basis
Earnings yield of 0.27% indicates that the stock is very expensive and has a negative EPS on a trailing 12-month basis
What is Earnings yield (E/P)?
Weak price momentum
Price Momentum score of 17.5 indicates that the stock has weak price momentum. Research has shown that stocks with lower momentum continue to underperform in the near term
What is Price Momentum score?
17.5 / 100
Low but stable ROE
The company reported low ROE of 2.85% for 12-month ended 30 Jun 2026 and ROE declined marginally by -108 bps from 1 year ago
What is ROE (FY)?
Low EPS growth and lower than median growth of industry
The company delivered moderate EPS growth of -393.82% for 12-month ended 30 Jun 2026 and the growth was 379.49 percentage points lower than median growth of industry
What is EPS growth (1Y)?
Company's earnings are of low quality
Earnings quality score of 22.1 indicates that the company's earnings are of low quality. Earnings quality is measured using combination of earnings persistence, probability of manipulation and earnings to cash conversion
What is Earnings quality score?
22.1 / 100
Low dividend yield
The company has a low dividend yield of 0.0%
What is Dividend yield?
Neutral
Low operating margin but improving trend
The company reported low operating margin of 5.12% for 12-month ended 30 Jun 2026 but operating margin improved by 38182 bps from 1 year ago
What is Operating profit margin?
Low Debt to Equity but increasing
The company has low Debt to Equity of 0.82 as on 30 Jun 2026 but Debt to Equity increased by 0.82 in the last 1 year
What is Debt to Equity?
Thinly traded (low daily turnover)
The stock is thinly traded with combined (NSE & BSE) daily turnover (21-day average) of 0.0110011.
Net Revenue FY
Profit After Tax FY
ROE FY
EBITDA FY
No corporate action data available.
Company Profile
Overview of Arvaya Healthcare Ltd. covering business description, industry classification, key management, financial ratios, and listed exchange details.
Arvaya Healthcare Limited, formerly Bijoy Hans Limited, is an India-based company. The Company is mainly engaged in the business of trading in bulk drugs, pharmaceuticals, cosmetics and investment. The Company offers various pharmaceutical formulations, such as tablets, capsules, syrups, suspension and powders, focusing on segments, such as Antibiotics, Cough/ Cold/ Allergy. H-1 Receptor Antagonist (Antiulcerant), Nutraceuticals and NSAIDS.
Arvaya Healthcare Limited, formerly Bijoy Hans Limited, is an India-based company. The Company is mainly engaged in the business of trading in bulk drugs, pharmaceuticals, cosmetics and investment. The Company offers various pharmaceutical formulations, such as tablets, capsules, syrups, suspension ...